Compare GFAI & BCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GFAI | BCTX |
|---|---|---|
| Founded | 2018 | 2014 |
| Country | Singapore | Canada |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.4M | 17.0M |
| IPO Year | N/A | N/A |
| Metric | GFAI | BCTX |
|---|---|---|
| Price | $0.76 | $9.27 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $4.50 | ★ $40.00 |
| AVG Volume (30 Days) | ★ 397.9K | 52.6K |
| Earning Date | 09-23-2025 | 12-11-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $36,987,715.00 | N/A |
| Revenue This Year | $5.66 | N/A |
| Revenue Next Year | $4.69 | $380.95 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 4.38 | N/A |
| 52 Week Low | $0.58 | $6.00 |
| 52 Week High | $3.88 | $98.20 |
| Indicator | GFAI | BCTX |
|---|---|---|
| Relative Strength Index (RSI) | 42.28 | 48.32 |
| Support Level | $0.75 | $8.55 |
| Resistance Level | $0.80 | $9.36 |
| Average True Range (ATR) | 0.06 | 1.03 |
| MACD | -0.00 | -0.15 |
| Stochastic Oscillator | 10.93 | 25.99 |
Guardforce AI Co Ltd is an integrated solution provider, specializing in security solutions, and also focuses on implementing AI and robotics solutions to improve business operational efficiency and sales and marketing processes, especially for the retail and travel industry in the Asia Pacific. The company's operating business segments include Secured Logistics, AI & Robotics Solution Business, General Security Solutions, and Corporate and others. A majority of its revenue is generated from the Secured Logistics segment, which includes services like cash-in-transit, dedicated vehicles to banks, ATM management, cash center operations, cash processing, coin processing, cheque center, and cash deposit machine solutions.
BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.